Free Trial

Royalty Pharma (RPRX) News Today

Royalty Pharma logo
$51.65 +0.86 (+1.69%)
Closing price 04:00 PM Eastern
Extended Trading
$50.92 -0.73 (-1.42%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

RPRX Latest News

Royalty Pharma (RPRX) Gets a Buy from TD Cowen
Royalty Pharma (NASDAQ:RPRX) Price Target Raised to $66.00
Royalty Pharma (NASDAQ:RPRX) Price Target Raised to $58.00
10% Of This Royalty Pharma Insider's Holdings Were Sold
Royalty Pharma: Q1 Earnings Snapshot
Royalty Pharma (RPRX) Q1 2026 Earnings Transcript
Royalty Pharma Q1 Earnings Call Highlights
Royalty Pharma reports first quarter 2026 results
Royalty Pharma Declares Second Quarter 2026 Dividend
Get Royalty Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for RPRX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RPRX Media Mentions By Week

RPRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RPRX
News Sentiment

0.71

0.43

Average
Medical
News Sentiment

RPRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RPRX Articles
This Week

25

5

RPRX Articles
Average Week

Get the Latest News and Ratings for RPRX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Royalty Pharma and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:RPRX) was last updated on 5/11/2026 by MarketBeat.com Staff.
From Our Partners